NCT03062787View on ClinicalTrials.gov

Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

October 25, 2017

Study Completion Date

October 25, 2017

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

Cingal® (Hyaluronic Acid plus Triamcinolone Hexacetonide)

Intra-articular injection

DEVICE

Monovisc® (Sodium hyaluronate)

Intra-articular injection

Trial Locations (5)

Unknown

Site 04, Barrie

Site 03, Hamilton

Site 02, Kanata

Site 05, Laval

Site 01, Québec

Sponsors

Lead Sponsor

Pharmascience Inc.
All Listed Sponsors
lead

Pharmascience Inc.

INDUSTRY

NCT03062787 - Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter